Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin
- 1 December 1999
- journal article
- research article
- Published by Wiley in Oral Microbiology and Immunology
- Vol. 14 (6) , 358-363
- https://doi.org/10.1034/j.1399-302x.1999.140605.x
Abstract
Opportunistic oral infections caused by Candida albicans and non‐albicans Candida species are particularly common in compromised patients. Nystatin, which belongs to the polyene group of antimycotics, is frequently used as a topical agent in the treatment of oro‐pharyngeal candidosis. It is recognized that due to the delivery mode of nystatin (i.e. topical, intermittent), as well as the cleansing effect of saliva within the oral environment, the yeasts undergo a relatively brief exposure to this drug during treatment. Nevertheless, there is a sparsity of data on the effect of such brief exposure to nystatin on the pathogenic attributes of Candida such as their adherence to host surfaces. The adhesion of microbes to host mucosal surfaces is a major determinant of successful colonization and infection. Thus the main aim of our investigation was to compare the in vitro adhesion of 30 oral isolates of Candida belonging to six different species (comprising Candida albicans, Candida tropicalis, Candida glabrata, Candida guilliermondii, Candida krusei and Candida parapsilosis) to human buccal epithelial cells, following their brief exposure (1 h) to minimum inhibitory concentration of nystatin, and subsequent removal of the drug. The adhesion of these isolates to buccal epithelial cells was assessed by a previously described adhesion assay. Compared with the controls, there was a significant reduction in buccal epithelial cell adhesion of all six Candida species after drug exposure (54%–68%). However the adhesion of C. albicans isolates was the least affected by nystatin exposure, which was significantly different from that of the non‐albicans species. These findings imply that sub‐therapeutic levels of nystatin, which are likely to persist in the oral cavity during dosing intervals, may also be beneficial, as they inhibit candidal colonization. The significant difference in nystatin‐induced suppression of adhesion between C. albicans and the non‐albicans species investigated is a further testimonial for the pre‐eminent virulence of the former species.Keywords
This publication has 32 references indexed in Scilit:
- Oral manifestations of HIV infection in 600 South African patientsJournal of Oral Pathology & Medicine, 2007
- Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agentsJournal of Oral Pathology & Medicine, 2007
- Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agentsArchives of Oral Biology, 1998
- The effect of limited exposure to antimycotics on the relative cell-surface hydrophobicity and the adhesion of oral Candida albicans to buccal epithelial cellsArchives of Oral Biology, 1998
- The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicansJournal of Oral Pathology & Medicine, 1998
- The in vitro adhesion of Candida albicans to buccal epithelial cells (BEC) from diabetic and non-diabetic individuals after in vivo and in vitro application of nystatinJournal of Oral Pathology & Medicine, 1997
- Molecular bases of adhesion ofCandida albicansMedical Mycology, 1997
- Treatment of oropharyngeal candidiasis in HIV-positive patientsJournal of the American Academy of Dermatology, 1994
- Treatment of Oral Candida Mucositis InfectionsDrugs, 1994
- Effects of Sub‐Inhibitory Concentrations of Antifungal Agents on Adherence of Candida spp. to Buccal Epithelial Cells in Vitro: Die Wirkung subinhibitorischer Antimyzetika‐Konzentrationen auf die Adharenz von Candida‐Arten an Epithelzellen der MundschleimhautMycoses, 1989